Jinno Akiko, Park Pyong Woo
Division of Respiratory Diseases, Children's Hospital, Harvard Medical School, 320 Longwood Avenue, Enders-461, Boston, MA, 02115, USA,
Methods Mol Biol. 2015;1229:567-85. doi: 10.1007/978-1-4939-1714-3_45.
Glycosaminoglycans (GAGs) have been shown to bind to a wide variety of microbial pathogens, including viruses, bacteria, parasites, and fungi in vitro. GAGs are thought to promote pathogenesis by facilitating pathogen attachment, invasion, or evasion of host defense mechanisms. However, the role of GAGs in infectious disease has not been extensively studied in vivo and therefore their pathophysiological significance and functions are largely unknown. Here we describe methods to directly investigate the role of GAGs in infections in vivo using mouse models of bacterial lung and corneal infection. The overall experimental strategy is to establish the importance and specificity of GAGs, define the essential structural features of GAGs, and identify a biological activity of GAGs that promotes pathogenesis.
糖胺聚糖(GAGs)已被证明在体外能与多种微生物病原体结合,包括病毒、细菌、寄生虫和真菌。人们认为GAGs通过促进病原体附着、入侵或逃避宿主防御机制来促进发病机制。然而,GAGs在传染病中的作用在体内尚未得到广泛研究,因此它们的病理生理意义和功能在很大程度上尚不清楚。在这里,我们描述了使用细菌性肺部和角膜感染的小鼠模型直接研究GAGs在体内感染中作用的方法。总体实验策略是确定GAGs的重要性和特异性,定义GAGs的基本结构特征,并确定促进发病机制的GAGs的生物活性。